Keyphrases
Glioblastoma
100%
B-cell Lymphoma 2 (Bcl-2)
100%
MiR-138
100%
Alkylator
100%
TMZ Resistance
50%
MicroRNA
37%
Cell Survival
25%
Tumor Progression
25%
Glioblastoma Cells
25%
Glioma Cells
25%
Cell Culture
12%
Cell Proliferation
12%
Population-based Study
12%
Autophagy
12%
Tissue Sampling
12%
Standard of Care
12%
Direct Target
12%
Radiotherapy
12%
Brain Tumor
12%
Functional Analysis
12%
Surgical Resection
12%
Tumor Recurrence
12%
Overexpression
12%
Apoptosis
12%
Transient Transfection
12%
Microarray
12%
Median Survival
12%
Resistance Mechanisms
12%
Resistance Phenotypes
12%
Recurrent Glioblastoma
12%
MicroRNA Profiling
12%
Acquired Resistance
12%
Glioblastoma Cell Lines
12%
Adjuvant Temozolomide
12%
Differentially Expressed microRNAs
12%
Human Glioma Cell Line
12%
Constitutive Resistance
12%
Apoptosis Regulators
12%
Glioma-initiating Cells
12%
Immunology and Microbiology
Glioma Cell
100%
Mediator
100%
Cell Survival
100%
Bcl-2
100%
Programmed Cell Death
100%
Cell Proliferation
50%
Transient Transfection
50%
Cell Culture
50%
Glioblastoma Cell Line
50%
Glioma Cell Line
50%
Autophagy
50%
In Vitro
50%
Medicine and Dentistry
Mediator
100%
microRNA
100%
Glioblastoma
100%
Programmed Cell Death
33%
Cell Survival
33%
Tumor Progression
33%
Glioma Cell
33%
In Vitro
16%
Autophagy
16%
Cell Proliferation
16%
Tumor Recurrence
16%
Transient Transfection
16%
Ganglioglioma
16%
Glioblastoma Cell Line
16%
Temozolomide
16%
Intracranial Tumor
16%
Glioma Cell Line
16%
Cell Culture
16%
Radiation Therapy
16%
Neuroscience
MicroRNA
100%
Bcl-2
100%
In Vivo
33%
Cell Line
33%
Cell Survival
33%
Programmed Cell Death
33%
In Vitro
16%
Cell Proliferation
16%
Transient Transfection
16%
Cell Culture
16%
Autophagy
16%
Intracranial Tumor
16%
Temozolomide
16%
Radiation Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Glioblastoma
100%
Tumor Growth
33%
Cell Culture
16%
Tumor Recurrence
16%
Temozolomide
16%
Intracranial Tumor
16%